Abbott Laboratories (ABT): Yawn All The Way to Retirement With It

Abbott Laboratories (NYSE:ABT) sees the need for improvement as opportunity and has high hopes for its diagnostics business. The innovative automated instruments provided to laboratories, clinics, and hospitals allow doctors to quickly and accurately diagnose disease like never before. They also represented 81.2% of the segment’s total revenue in the first quarter.

The company boasts 10 platforms that address the quickly expanding fields of immunology (various ailments), hematology (blood analysis), and molecular biology (genetic analysis). Why stop there? A total of six new platforms are being developed, including the ultra-awesome universal-microbe-detecting-PLEX-ID.

Look for the growth to pick up in coming periods: Operating margin for diagnostics is currently “on track to exceed its full-year target of 20% by 2015,” according to the company. Despite the progress, I would like to see Abbott Laboratories (NYSE:ABT) expand its presence in molecular technologies, which bring in just 10% of total diagnostics revenue. The ability to detect a patient’s genetic susceptibility to disease will become increasingly important in the future of medicine.

Foolish bottom line

I can’t promise that Abbott Laboratories (NYSE:ABT) stock won’t cool off from its recent all-time highs. However, the company is as determined as ever to expand its market dominance in cardiovascular devices to diagnostics and increase its presence in nutrition. AbbVie Inc (NYSE:ABBV) may have taken most of the former giant’s dividend with it, but it faces problems of its own with Humira coming off patent in a few years. Boring ol’ Abbott faces no such patent cliff and can continue to grow slow and steady for years to come. Put it on your watchlist, maybe grab some shares, and yawn your way to market-beating returns.

The article Yawn Your Way to Retirement With Abbott Laboratories Stock originally appeared on Fool.com and is written by Maxx Chatsko.

Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio or his CAPS page, or follow him on Twitter, @BlacknGoldFool, to keep up with his writing on energy, bioprocessing, and emerging technologies. The Motley Fool recommends and owns shares of Johnson & Johnson.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!